Fifth Third Bancorp
RCUS icon

Fifth Third Bancorp’s Arcus Biosciences RCUS Stock Holding History

Fifth Third Bancorp’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$611K Sell
19,822
-349
-2% -$8.63K ﹤0.01% 1982
2026
Q1 		$436K Buy
20,171
+18,660
+1,235% +$403K ﹤0.01% 2110
2025
Q4 		$36K Buy
1,511
+24
+2% +$490 ﹤0.01% 1619
2025
Q3 		$20.2K Buy
1,487
+533
+56% +$5.54K ﹤0.01% 1884
2025
Q2 		$7.77K Buy
954
+43
+5% +$367 ﹤0.01% 2092
2025
Q1 		$7.15K Buy
911
+625
+219% +$7.25K ﹤0.01% 2112
2024
Q4 		$4.26K Sell
286
-180
-39% -$2.94K ﹤0.01% 2196
2024
Q3 		$7.13K Buy
466
+24
+5% +$378 ﹤0.01% 2095
2024
Q2 		$6.73K Buy
442
+305
+223% +$4.92K ﹤0.01% 2044
2024
Q1 		$2.59K Buy
137
+114
+496% +$1.97K ﹤0.01% 2191
2023
Q4 		$439 Sell
23
-31
-57% -$495 ﹤0.01% 2455
2023
Q3 		$969 Sell
54
-150
-74% -$3.01K ﹤0.01% 2461
2023
Q2 		$4.14K Buy
+204
New +$3.88K ﹤0.01% 2257
2023
Q1 		– Sell
-665
Closed -$13.8K – 2824
2022
Q4 		$13.8K Hold
665
– – ﹤0.01% 1833
2022
Q3 		$17K Hold
665
– – ﹤0.01% 1761
2022
Q2 		$17K Buy
+665
New +$16.3K ﹤0.01% 1802

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Fifth Third Bancorp's RCUS Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Arcus Biosciences (RCUS) stake by 1.7% in Q2 2026, selling an estimated $8.63K and leaving 19,822 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #1982.

Fifth Third Bancorp first reported a position in RCUS in Q2 2022 and has held it in 16 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Fifth Third Bancorp held 19,822 shares of Arcus Biosciences worth $611K as of Q2 2026.
  • Fifth Third Bancorp sold 349 Arcus Biosciences shares in Q2 2026, an estimated $8.63K.
  • Arcus Biosciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1982 holding.
  • Fifth Third Bancorp first reported a position in Arcus Biosciences in Q2 2022 and has held it in 16 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.